IT1317937B1 - Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina. - Google Patents

Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.

Info

Publication number
IT1317937B1
IT1317937B1 IT2000RM000601A ITRM20000601A IT1317937B1 IT 1317937 B1 IT1317937 B1 IT 1317937B1 IT 2000RM000601 A IT2000RM000601 A IT 2000RM000601A IT RM20000601 A ITRM20000601 A IT RM20000601A IT 1317937 B1 IT1317937 B1 IT 1317937B1
Authority
IT
Italy
Prior art keywords
lattoferrina
carnitina
alcanoil
metabolism
composition
Prior art date
Application number
IT2000RM000601A
Other languages
English (en)
Inventor
Pietro Pola
Original Assignee
Sigma Tau Healthscience Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Healthscience Spa filed Critical Sigma Tau Healthscience Spa
Priority to IT2000RM000601A priority Critical patent/IT1317937B1/it
Publication of ITRM20000601A0 publication Critical patent/ITRM20000601A0/it
Priority to PCT/IT2001/000395 priority patent/WO2002040013A1/en
Priority to AU2001277688A priority patent/AU2001277688A1/en
Publication of ITRM20000601A1 publication Critical patent/ITRM20000601A1/it
Application granted granted Critical
Publication of IT1317937B1 publication Critical patent/IT1317937B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00—Food ingredients
    • A23V2250/54—Proteins
    • A23V2250/542—Animal Protein
    • A23V2250/5424—Dairy protein
    • A23V2250/54248—Lactoferrin
IT2000RM000601A 2000-11-17 2000-11-17 Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina. IT1317937B1 (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IT2000RM000601A IT1317937B1 (it) 2000-11-17 2000-11-17 Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.
PCT/IT2001/000395 WO2002040013A1 (en) 2000-11-17 2001-07-24 Composition for stimulating the immune defence and iron metabolism, containing propionyl l-carnitine and lactoferrin
AU2001277688A AU2001277688A1 (en) 2000-11-17 2001-07-24 Composition for stimulating the immune defence and iron metabolism, containing propionyl l-carnitine and lactoferrin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2000RM000601A IT1317937B1 (it) 2000-11-17 2000-11-17 Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.

Publications (3)

Publication Number Publication Date
ITRM20000601A0 ITRM20000601A0 (it) 2000-11-17
ITRM20000601A1 ITRM20000601A1 (it) 2002-05-17
IT1317937B1 true IT1317937B1 (it) 2003-07-15

Family

ID=11455001

Family Applications (1)

Application Number Title Priority Date Filing Date
IT2000RM000601A IT1317937B1 (it) 2000-11-17 2000-11-17 Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.

Country Status (3)

Country Link
AU (1) AU2001277688A1 (it)
IT (1) IT1317937B1 (it)
WO (1) WO2002040013A1 (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057245A1 (fr) * 2001-12-28 2003-07-17 Nrl Pharma, Inc. Compositions servant a ameliorer le metabolisme lipidique
JP2006515879A (ja) * 2003-01-07 2006-06-08 エヌ．ブイ．・ヌートリシア 哺乳類による栄養利用を向上するための方法およびその中で使用するための組成物
SE528337C2 (sv) * 2004-06-23 2006-10-24 Nestor Medical Ab Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet
CA3130389C (en) * 2019-04-18 2024-01-16 Simo Rasi Composition for use in prevention or reduction of oxidative stress and neurodegenerative diseases
US20230346735A1 (en) * 2020-04-28 2023-11-02 Lonza Greenwood Llc Nutritional Composition Comprising Carnitine and Method for Treating or Preventing an Infection in a Mammal

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2090658A1 (en) * 1992-03-02 1993-09-03 Kunio Ando Formulated medicine for treatment and/or prevention of opportunistic infectious diseases complicated by infection with lentivirus
IT1278137B1 (it) * 1995-07-12 1997-11-17 Piera Valenti Utilizzo della lattoferrina per la terapia topica delle infezioni acute o recidivanti causate da "streptococcus pyogenes" o da altri
IT1290801B1 (it) * 1996-07-05 1998-12-11 Mendes Srl Uso della acetil l-carnitina, della isovaleril l-carnitina, della propionil l-carnitina o dei loro sali farmacologicamente accettabili

Also Published As

Publication number Publication date
WO2002040013A1 (en) 2002-05-23
ITRM20000601A0 (it) 2000-11-17
AU2001277688A1 (en) 2002-05-27
ITRM20000601A1 (it) 2002-05-17

Similar Documents

Publication Publication Date Title
DE60108417D1 (de) Herzstimulationsvorrichtung
PL401469A1 (pl) Pochodna azabicykliczna, sposób jej wytwarzania, jej zastosowanie w medycynie oraz zawierajaca pochodna kompozycja
AU4244200A (en) Multi-functional therapeutic compress and methods of using the same
NO20013332D0 (no) Frac-plugg med kulehylse
IL151517A0 (en) Therapeutic uses of ppar mediators
IS6575A (is) Hýdroxýfenýl-píperidín-4-ýlíden-metýl-bensamíðafleiður til að meðhöndla sársauka
DK1434507T3 (da) Forbedringer til seng-og-bord-kombinationsmöbel
EP1307211A4 (en) IMMUNE MEDIATOR AND ASSOCIATED METHODS
ATE387204T1 (de) Zusammensetzung mit induzierendem kathartischen effekt
DE10194786T1 (de) Zusammensetzungen zur Verstärkung der Immunantwort
IS6563A (is) Hýdroxýfenýl-píperasinýl-metýl-bensamíðafleiður til að meðhöndla sársauka
NO20031525L (no) Kjemokinmutanter i behandlingen av multippel sklerose
AU2002243363A8 (en) Use of aziridino-compounds in the treatment of immune dysfunctions
IT1317937B1 (it) Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina.
DE60124516D1 (de) Kombination des lezithins mit ascorbinsäure
NO20014184L (no) Magnetisk kjerne med en effektiv formagnetisering og magnetisk anordning medanvendelse av kjernen
GB2390543B (en) Improvements in and relating to the administration of copper to an animal
ITRM20000602A0 (it) Composizione per la prevenzione e/o il trattamento di alterazioni delmetabolismo lipidico, delle forme allergiche e per attivare le difese
PL362577A1 (en) Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity
AU6604701A (en) Method to induce the TH1 immune response
EP1264600A4 (en) IMMUNITY-BUILDING COMPOSITION AND USE OF SUCH COMPOSITIONS
GB0007217D0 (en) Materials and methods relating to the treatment of leukaemias
IT1318263B1 (it) Dispositivo massaggiatore da inserire all'interno dello schienale dipoltrona di massaggio o simili.
GB0012193D0 (en) Materials and methods relating to encapsulation
GB0014437D0 (en) Immune response stimulation